No abstract available
Plain language summary
This Viewpoint discusses financial barriers for additional diagnostic steps after patients receive abnormal cancer screening test results.
MeSH terms
-
Early Detection of Cancer* / methods
-
Female
-
Humans
-
Insurance Coverage
-
Mass Screening / methods
-
Neoplasms / diagnosis
-
Neoplasms / epidemiology
-
United States / epidemiology